20th Aug 2007 13:08
GlaxoSmithKline PLC20 August 2007 This announcement replaces the original announcement released on 16/08/07 at 17:22, RNS No: 2874C. The amount of treasury shares held as % of total voting rights in the Companyshould have read 6.40% and not 6.34% as previously stated. All other detailsremain unchanged. The amended text appears below GlaxoSmithKline plc (the "Company") announces that in accordance with theauthority granted by shareholders at the Company's Annual General Meeting on 23May 2007 it purchased 3,150,000 of its Ordinary shares of 25 pence each("shares") on 16 August at a price of 1,234.38 pence per share. The Company intends to hold these shares in Treasury. Following the purchase of these shares, the Company holds 362,412,158 of itsshares in Treasury, representing 6.40% of the total voting rights in theCompany. The Company has 5,659,804,888 shares in issue (excluding Treasury shares). Thisnumber represents the total voting rights in the Company and may be used byshareholders as the denominator for the calculations by which they can determineif they are required to notify their interest in, or a change to their interestin the Company under the Financial Services Authority's Disclosure andTransparency Rules. This announcement does not constitute, or form part of, an offer or anysolicitation of an offer to purchase or subscribe for securities in anyjurisdiction and is in conformity with the Financial Services Authority'sDisclosure and Transparency Rules. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline